Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation

Michael Huo, Arjun Sahgal, David Pryor, Kristin A Redmond, Simon Lo, Matthew Foote

Research output: Contribution to journalReview article

Abstract

Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment option for spinal metastases with demonstrated efficacy in the upfront, postoperative, and re-treatment settings, as well as for tumor histologies considered radioresistant. Uncertainty exists regarding the optimal dose and fractionation schedule, with single and multifraction regimens commonly utilized. Methods: A literature search of the PubMed and Medline databases was conducted to identify papers specific to spine SBRT and the effect of varying dose/fractionation regimens on outcomes. Bibliographies of relevant papers were searched for further references, and international spine SBRT experts were consulted. Results: Local control rates generally exceed 80% at 1 year, while high rates of pain control have been attained. There is insufficient evidence to suggest superiority of either single or multiple fraction regimens with respect to local control and pain control. Low rates of toxicity have been reported, assuming strict dose constraints are respected. Radiation myelopathy may be the most morbid toxicity, although the rates are low. The risk of vertebral compression fracture appears to be associated with higher doses per fraction such as those used in single-fraction regimens. The Spinal Instability Neoplastic Score should be considered when evaluating patients for spine SBRT, and prophylactic stabilisation may be warranted. Pain flare is a relatively common toxicity which may be mediated with prophylactic dexamethasone. Because of the treatment complexity and potentially serious toxicities, strict quality assurance should occur at the organizational, planning, dosimetric, and treatment delivery levels. Conclusion: Both single and multifraction regimens are safe and efficacious in spine SBRT for spinal metastases. There may be advantages to hypofractionated treatment over single-fraction regimens with respect to toxicity. Ongoing investigation is underway to define optimal dose and fractionation schedules.

Original languageEnglish (US)
JournalSurgical Neurology International
Volume8
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Dose Fractionation
Radiosurgery
Spine
Safety
Pain
Appointments and Schedules
Neoplasm Metastasis
Therapeutics
Compression Fractures
Spinal Cord Diseases
Bibliography
PubMed
Dexamethasone
Uncertainty
Histology
Databases
Radiation
Neoplasms

Keywords

  • Metastases
  • Radiotherapy
  • SBRT
  • Spine
  • Stereotactic body radiation

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Stereotactic spine radiosurgery : Review of safety and efficacy with respect to dose and fractionation. / Huo, Michael; Sahgal, Arjun; Pryor, David; Redmond, Kristin A; Lo, Simon; Foote, Matthew.

In: Surgical Neurology International, Vol. 8, No. 1, 2017.

Research output: Contribution to journalReview article

Huo, Michael ; Sahgal, Arjun ; Pryor, David ; Redmond, Kristin A ; Lo, Simon ; Foote, Matthew. / Stereotactic spine radiosurgery : Review of safety and efficacy with respect to dose and fractionation. In: Surgical Neurology International. 2017 ; Vol. 8, No. 1.
@article{41750470c3c04c20acb07abc91ca8c95,
title = "Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation",
abstract = "Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment option for spinal metastases with demonstrated efficacy in the upfront, postoperative, and re-treatment settings, as well as for tumor histologies considered radioresistant. Uncertainty exists regarding the optimal dose and fractionation schedule, with single and multifraction regimens commonly utilized. Methods: A literature search of the PubMed and Medline databases was conducted to identify papers specific to spine SBRT and the effect of varying dose/fractionation regimens on outcomes. Bibliographies of relevant papers were searched for further references, and international spine SBRT experts were consulted. Results: Local control rates generally exceed 80{\%} at 1 year, while high rates of pain control have been attained. There is insufficient evidence to suggest superiority of either single or multiple fraction regimens with respect to local control and pain control. Low rates of toxicity have been reported, assuming strict dose constraints are respected. Radiation myelopathy may be the most morbid toxicity, although the rates are low. The risk of vertebral compression fracture appears to be associated with higher doses per fraction such as those used in single-fraction regimens. The Spinal Instability Neoplastic Score should be considered when evaluating patients for spine SBRT, and prophylactic stabilisation may be warranted. Pain flare is a relatively common toxicity which may be mediated with prophylactic dexamethasone. Because of the treatment complexity and potentially serious toxicities, strict quality assurance should occur at the organizational, planning, dosimetric, and treatment delivery levels. Conclusion: Both single and multifraction regimens are safe and efficacious in spine SBRT for spinal metastases. There may be advantages to hypofractionated treatment over single-fraction regimens with respect to toxicity. Ongoing investigation is underway to define optimal dose and fractionation schedules.",
keywords = "Metastases, Radiotherapy, SBRT, Spine, Stereotactic body radiation",
author = "Michael Huo and Arjun Sahgal and David Pryor and Redmond, {Kristin A} and Simon Lo and Matthew Foote",
year = "2017",
doi = "10.4103/2152-7806.200581",
language = "English (US)",
volume = "8",
journal = "Surgical Neurology International",
issn = "2152-7806",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - Stereotactic spine radiosurgery

T2 - Review of safety and efficacy with respect to dose and fractionation

AU - Huo, Michael

AU - Sahgal, Arjun

AU - Pryor, David

AU - Redmond, Kristin A

AU - Lo, Simon

AU - Foote, Matthew

PY - 2017

Y1 - 2017

N2 - Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment option for spinal metastases with demonstrated efficacy in the upfront, postoperative, and re-treatment settings, as well as for tumor histologies considered radioresistant. Uncertainty exists regarding the optimal dose and fractionation schedule, with single and multifraction regimens commonly utilized. Methods: A literature search of the PubMed and Medline databases was conducted to identify papers specific to spine SBRT and the effect of varying dose/fractionation regimens on outcomes. Bibliographies of relevant papers were searched for further references, and international spine SBRT experts were consulted. Results: Local control rates generally exceed 80% at 1 year, while high rates of pain control have been attained. There is insufficient evidence to suggest superiority of either single or multiple fraction regimens with respect to local control and pain control. Low rates of toxicity have been reported, assuming strict dose constraints are respected. Radiation myelopathy may be the most morbid toxicity, although the rates are low. The risk of vertebral compression fracture appears to be associated with higher doses per fraction such as those used in single-fraction regimens. The Spinal Instability Neoplastic Score should be considered when evaluating patients for spine SBRT, and prophylactic stabilisation may be warranted. Pain flare is a relatively common toxicity which may be mediated with prophylactic dexamethasone. Because of the treatment complexity and potentially serious toxicities, strict quality assurance should occur at the organizational, planning, dosimetric, and treatment delivery levels. Conclusion: Both single and multifraction regimens are safe and efficacious in spine SBRT for spinal metastases. There may be advantages to hypofractionated treatment over single-fraction regimens with respect to toxicity. Ongoing investigation is underway to define optimal dose and fractionation schedules.

AB - Background: Stereotactic body radiotherapy (SBRT) is an emerging treatment option for spinal metastases with demonstrated efficacy in the upfront, postoperative, and re-treatment settings, as well as for tumor histologies considered radioresistant. Uncertainty exists regarding the optimal dose and fractionation schedule, with single and multifraction regimens commonly utilized. Methods: A literature search of the PubMed and Medline databases was conducted to identify papers specific to spine SBRT and the effect of varying dose/fractionation regimens on outcomes. Bibliographies of relevant papers were searched for further references, and international spine SBRT experts were consulted. Results: Local control rates generally exceed 80% at 1 year, while high rates of pain control have been attained. There is insufficient evidence to suggest superiority of either single or multiple fraction regimens with respect to local control and pain control. Low rates of toxicity have been reported, assuming strict dose constraints are respected. Radiation myelopathy may be the most morbid toxicity, although the rates are low. The risk of vertebral compression fracture appears to be associated with higher doses per fraction such as those used in single-fraction regimens. The Spinal Instability Neoplastic Score should be considered when evaluating patients for spine SBRT, and prophylactic stabilisation may be warranted. Pain flare is a relatively common toxicity which may be mediated with prophylactic dexamethasone. Because of the treatment complexity and potentially serious toxicities, strict quality assurance should occur at the organizational, planning, dosimetric, and treatment delivery levels. Conclusion: Both single and multifraction regimens are safe and efficacious in spine SBRT for spinal metastases. There may be advantages to hypofractionated treatment over single-fraction regimens with respect to toxicity. Ongoing investigation is underway to define optimal dose and fractionation schedules.

KW - Metastases

KW - Radiotherapy

KW - SBRT

KW - Spine

KW - Stereotactic body radiation

UR - http://www.scopus.com/inward/record.url?scp=85020380059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020380059&partnerID=8YFLogxK

U2 - 10.4103/2152-7806.200581

DO - 10.4103/2152-7806.200581

M3 - Review article

C2 - 28303210

AN - SCOPUS:85020380059

VL - 8

JO - Surgical Neurology International

JF - Surgical Neurology International

SN - 2152-7806

IS - 1

ER -